Name | BI 703704 |
---|
Description | A novel potent soluble guanylate cyclase (sGC) activator; reduces progression of renal damage in the ZSF1 rat, shows the potential as an effective therapy for diabetic nephropathy. |
---|---|
Related Catalog | |
In Vivo | (Rac)-BI 703704 (0.3-10 mg/kg; food intake; daily for 15 weeks) inhibits the progression of diabetic nephropathy in the ZSF1 rat[1]. Animal Model: 12-13 weeks male ZSF1 obese rats[1] Dosage: 0.3, 1, 3, or 10 mg/kg Administration: Food intake; daily for 15 weeks Result: Dose-dependent increased in renal cGMP levels; Dosedependent decreased in urinary protein excretion (UPE); Accompanied by a significant reduction in the incidence of glomerulosclerosis and interstitial lesions. |
References |
Molecular Formula | C32H37N3O4S |
---|---|
Molecular Weight | 559.725 |